Skip to content
Unrated Drug recall · FDA · Published May 7, 2025

Alembic Recalls Bromfenac Eye Drops Due to Impurity Failures

Alembic Pharmaceuticals recalls specific lots of Bromfenac Ophthalmic Solution 0.09% due to failed impurity specifications. Check your lot numbers immediately.

🇺🇸 FDA recall #D-0447-2025DrugAlembic Pharmaceuticals ›
Take action

Contact the company

Recalling firmAlembic Pharmaceuticals LimitedFormulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol · Panchmahal, India
✎ GovInfoNow plain-language explainer

What happened, in plain English

Alembic Pharmaceuticals Limited has recalled Bromfenac Ophthalmic Solution 0.09% because the product failed impurity and degradation specifications. The recall affects specific lots distributed nationwide in the United States. The record does not specify the exact health risks associated with these impurities or provide a remedy for consumers. Read more at govinfonow.com/recall/32086-alembic-recalls-bromfenac-eye-drops-due-to-impurity-failures.

Source Summary by GovInfoNow · govinfonow.com/recall/32086-alembic-recalls-bromfenac-eye-drops-due-to-impurity-failures · Updated October 9, 2026 · FDA enforcement record: FDA #D-0447-2025

Cite this page

“Alembic Recalls Bromfenac Eye Drops Due to Impurity Failures.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32086-alembic-recalls-bromfenac-eye-drops-due-to-impurity-failures. Based on FDA recall #D-0447-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0447-2025%22&limit=1).

Why it’s dangerous

The recalled eye drops failed to meet specifications for impurities and degradation. The record does not explain what these impurities are or how they might cause injury, so the specific danger mechanism is unknown based on this text.

Who’s affected

Consumers in the United States who have been prescribed Bromfenac Ophthalmic Solution 0.09% from Alembic Pharmaceuticals. Individuals using the specific lots listed below are at risk of receiving non-compliant product.

How to tell if you have this one

Check your bottle for NDC 62332-508-17. Verify the lot number and expiration date against the following: Lot 7230309 (Exp 5/31/2025), Lot 7230310 (Exp 5/31/2025), or Lot 7230311 (Exp 5/31/2025). The product is a 1.7 mL sterile bottle.

  • Brand
    Alembic Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your Bromfenac Ophthalmic Solution matches the recalled NDC and lot numbers listed in the record.

  2. Consult Your Pharmacist

    Contact your healthcare provider or pharmacist for guidance on what to do with the product, as no specific remedy is stated in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: May 7, 202512. FDA classified it Class II: May 27, 202523. Published in FDA’s Enforcement Report: Jun 4, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0447-2025 (May 7, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0447-2025 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA